{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "19105653", "DateCompleted": {"Year": "2009", "Month": "02", "Day": "19"}, "DateRevised": {"Year": "2024", "Month": "03", "Day": "23"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": ["10.1021/np800653z"], "Journal": {"ISSN": "1520-6025", "JournalIssue": {"Volume": "72", "Issue": "1", "PubDate": {"Year": "2009", "Month": "Jan"}}, "Title": "Journal of natural products", "ISOAbbreviation": "J Nat Prod"}, "ArticleTitle": "Indolizidine, antiinfective and antiparasitic compounds from Prosopis glandulosa var. glandulosa.", "Pagination": {"StartPage": "92", "EndPage": "98", "MedlinePgn": "92-8"}, "Abstract": {"AbstractText": ["A new potent antiinfective and antiparasitic 2,3-dihydro-1H-indolizinium chloride (1) was isolated from Prosopis glandulosa var. glandulosa. Three additional new (2-4) and one known (5) indolizidines were also isolated, and the dihydrochloride salts of 1-3 (compounds 6, 7, and 8) were prepared. Structures were determined by 1D and 2D NMR and mass spectra. Compound 1 showed potent in vitro antifungal activity against Cryptococcus neoformans and Aspergillus fumigatus (IC(50) values = 0.4 and 3.0 microg/mL, respectively) and antibacterial activity against methicillin-resistant Staphylococcus aureus and Mycobacterium intracellulare (IC(50) values of 0.35 and 0.9 microg/mL, respectively). The remarkable in vitro fungicidal activity of 1-4 against C. neoformans (MFCs = 0.63-1.25 microg/mL) and 2, 3, and 5 against A. fumigatus (MFCs = 0.63-2.5 microg/mL) were similar to amphotericin B, but >2-4-fold more potent than 6-8. Prosopilosidine (1) showed potent in vivo activity at 0.0625 mg/kg/day/ip for 5 days in a murine model of cryptococcosis by eliminating approximately 76% of C. neoformans infection from brain tissue compared to approximately 83% with amphotericin B at 1.5 mg/kg/day. Compounds 1 and 4 exhibited potent activity and high selectivity index (SI) values against chloroquine-sensitive (D6) and chloroquine-resistant (W2) strains of Plasmodium falciparum, with IC(50) values of 39 and 95 ng/mL and 42 and 120 ng/mL, respectively (chloroquine, IC(50) = 17 and 140 ng/mL). Prosopilosine (1) also showed in vivo antimalarial activity, with an ED(50) value of approximately 2 mg/kg/day/ip against Plasmodium berghei-infected mice after 3 days of treatment."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "National Center for Natural Products Research and Department of Pharmacology, Research Institute of Pharmaceutical Sciences, School of Pharmacy, University of Mississippi, University, Mississippi 38677, USA."}], "Identifier": [], "LastName": "Samoylenko", "ForeName": "Volodymyr", "Initials": "V"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Ashfaq", "ForeName": "Mohammad K", "Initials": "MK"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Jacob", "ForeName": "Melissa R", "Initials": "MR"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Tekwani", "ForeName": "Babu L", "Initials": "BL"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Khan", "ForeName": "Shabana I", "Initials": "SI"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Manly", "ForeName": "Susan P", "Initials": "SP"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Joshi", "ForeName": "Vaishali C", "Initials": "VC"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Walker", "ForeName": "Larry A", "Initials": "LA"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Muhammad", "ForeName": "Ilias", "Initials": "I"}], "GrantList": [{"GrantID": "R01 AI027094", "Acronym": "AI", "Agency": "NIAID NIH HHS", "Country": "United States"}, {"GrantID": "AI 27094", "Acronym": "AI", "Agency": "NIAID NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Research Support, N.I.H., Extramural", "Research Support, Non-U.S. Gov't", "Research Support, U.S. Gov't, Non-P.H.S."]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "J Nat Prod", "NlmUniqueID": "7906882", "ISSNLinking": "0163-3864"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Infective Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Antiparasitic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Indolizidines"}, {"RegistryNumber": "886U3H6UFF", "NameOfSubstance": "Chloroquine"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["chemistry", "isolation & purification", "pharmacology"], "DescriptorName": "Anti-Infective Agents"}, {"QualifierName": ["chemistry", "isolation & purification", "pharmacology"], "DescriptorName": "Antiparasitic Agents"}, {"QualifierName": ["drug effects"], "DescriptorName": "Aspergillus fumigatus"}, {"QualifierName": ["drug effects"], "DescriptorName": "Brain"}, {"QualifierName": ["drug effects"], "DescriptorName": "Candida albicans"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Chloroquine"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cryptococcus neoformans"}, {"QualifierName": [], "DescriptorName": "Disease Models, Animal"}, {"QualifierName": [], "DescriptorName": "Drug Screening Assays, Antitumor"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["chemistry", "isolation & purification", "pharmacology"], "DescriptorName": "Indolizidines"}, {"QualifierName": [], "DescriptorName": "Inhibitory Concentration 50"}, {"QualifierName": ["drug effects"], "DescriptorName": "Methicillin-Resistant Staphylococcus aureus"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Microbial Sensitivity Tests"}, {"QualifierName": [], "DescriptorName": "Molecular Structure"}, {"QualifierName": [], "DescriptorName": "Nevada"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["drug effects"], "DescriptorName": "Plasmodium berghei"}, {"QualifierName": ["chemistry"], "DescriptorName": "Prosopis"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Burkhart A. A Monograph of the Genus Prosopis. J Arnold Arboretum. 1976;57:450\u2013525."}, {"Citation": "Hilu YW, Boyd S, Felker P. Morphological diversity and taxonomy of California mesquites (Prosopis, Lepminosae) Madrono. 1982;29:237\u2013254."}, {"Citation": "Davidow J. Infusions of Healing: A Treasury of Mexican-American Herbal Remedies. Simon and Schuster Inc; 1999. pp. 1\u2013149."}, {"Citation": "Kay MA. Healing with Plants in the American and Mexican West. The University of Arizona Press; Tuscon: 1996. pp. 221\u2013224."}, {"Citation": "Ali AAN, Al-Rahwi K, Lindequist U. Afr J Trad, Complementary & Alt Med. 2004;1:72\u201376."}, {"Citation": "Ahmad VU, Qazi S. J Chem Soc Pak. 1985;7:347\u2013350."}, {"Citation": "Ahmad VU, Basha A, Haque W. Zeitschrift fuer Naturforschung, Teil B: Anorganische Chemie, Organische Chemie. 1978;33B:347\u2013348."}, {"Citation": "Daetwyler P, Ott-Longoni R, Schoepp E, Hesse M. Helv Chim Acta. 1981;64:1959\u20131963."}, {"Citation": "Ahmad VU, Sultana A, Qazi S. Alkaloids from the leaves of Prosopis juliflora. J Nat Prod. 1989;52:497\u2013501."}, {"Citation": "Nakano H, Nakajima E, Hiradate S, Fujii Y, Yamada K, Shigemori H, Hasegawa K. Phytochem. 2004;65:587\u2013591.", "ArticleIdList": ["15003422"]}, {"Citation": "Ahmad VU, Ali MS, Bano N, Bano S, Fatima A, Fatima I, Fizza K, Farooqui TA, Khan MA. Nat Prod Chem. Vol. 3. Springer-Verlag; Berlin: 1988. pp. 355\u2013358."}, {"Citation": "Snider BB, Neubert BJ. Org Lett. 2005;7:2715\u20132718.", "ArticleIdList": ["15957929"]}, {"Citation": "Aqeel A, Khursheed AK, Viqaruddin A, Sabiha Q. Arzneimittel-Forschung. 1989;39:652\u2013655.", "ArticleIdList": ["2775330"]}, {"Citation": "Ahmad A, Ahmad V, Khalid SM, Ansari FA, Khan KA. Philippine J Sci. 1997;126:175\u2013182."}, {"Citation": "Ahmad A, Khan KA, Ahmad V. Pak J of Zoology. 1996;28:365\u2013367."}, {"Citation": "Ahmad A, Khan KA, Ahmad VU, Qazi S. Planta Med. 1986;4:285\u2013288.", "ArticleIdList": ["3763718"]}, {"Citation": "Ahmad A, Kazmi SU, Khan KA, Ahmad VU, Qazi S. JPMA J Pak Med Asson. 1988;38:20\u201324.", "ArticleIdList": ["3130500"]}, {"Citation": "Khursheed AK, Arshad HF, Viqaruddin A, Sabiha Q, Sheikh AR, Tahir SH. Arzneimittel-Forschung. 1986;36:17\u201319.", "ArticleIdList": ["3513775"]}, {"Citation": "Ahmad A, Khursheed AK, Sabiha Q, Viqaruddin A. Fitoterapia. 1989;60:86\u201389."}, {"Citation": "Tabassum R, Naqvi SNH, Ahmad VU, Rani S, Jahan M, Azmi MA. Proceedings of Pakistan Congress of Zoology. 1994;14:326\u2013333."}, {"Citation": "Naqvi SNH, Yasmin N, Mahmood RA, Nizam S, Ahmad VU, Qazi S. Zeitschriftfuer Angewandte Zoologie. 1994;80:155\u2013164."}, {"Citation": "Aqeel A, Khursheed AK, Viqaruddin A. Toxicological studies of the antimicrobial alkaloid juliflorine. Arzneimittel-Forschung. 1991;41:151\u2013154.", "ArticleIdList": ["2043177"]}, {"Citation": "Tapia A, Egly Feresin G, Bustos D, Astudillo L, Theoduloz C, Schmeda-Hirschmann G. J of Ethnopharmacol. 2000;71:241\u2013246.", "ArticleIdList": ["10904169"]}, {"Citation": "Nakano H, Nakajima E, Fujii Y, Shigemori H, Hasegawa K. Plant Growth Regulation. 2004;44:207\u2013210."}, {"Citation": "Usmanghani K, Saqib QN, Ahmad VU. J Chem Soc Pak. 1982;4:285\u2013287."}, {"Citation": "Ott-Longoni R, Viswanathan N, Hesse M. Helv Chim Acta. 1980;6:2119\u20132129."}, {"Citation": "Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Adv Drug Delivery Rev. 1997;23:3\u201325.", "ArticleIdList": ["11259830"]}, {"Citation": "NCCLS. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard. National Committee for Clinical Laboratory Standards. (2) 2002;22:1\u201351."}, {"Citation": "NCCLS. Reference method for broth dilution antifungal susceptibility testing of conidium forming filamentous fungi. Proposed standard M38-P. National Committee for Clinical Laboratory Standards. 1998;18:1\u201339."}, {"Citation": "NCCLS. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. NCCLS Document M7-A5. National Committee for Clinical Laboratory Standards. 2000;20:1\u201358."}, {"Citation": "NCCLS. Susceptibility testing of mycobacteria, nocardia, and other aerobic actinomycetes. Tentative standard M24-T2. National Committee for Clinical Laboratory Standards. (2) 2000;20:1\u201381.", "ArticleIdList": ["31339680"]}, {"Citation": "Franzblau SG, Witzig RS, McLaughlin JC, Torres P, Madico G, Hernandez A, Degnan MT, Cook MB, Quenzer VK, Ferguson RM, Gilman RH. J Clinical Microbiol. 1998:362\u2013366.", "ArticleIdList": ["PMC104543", "9466742"]}, {"Citation": "Dou J, McChesney JD, Sindelar RD, Goins DK, Walker LA. J Nat Prod. 1996;59:73\u201376.", "ArticleIdList": ["8984156"]}, {"Citation": "Makler MT, Hinrichs DJ. Am J Trop Med & Hygiene. 1993;48:205\u2013210.", "ArticleIdList": ["8447524"]}, {"Citation": "Makler MT, Ries JM, Williams JA, Bancroft JE, Piper RC, Gibbins BL, Hinrichs DJ. Am J Trop Med & Hygiene. 1993;48:739\u2013741.", "ArticleIdList": ["8333566"]}, {"Citation": "Peters W, Portus JH, Robinson BL. Annals of Trop Med Parasitol. 1975;69:155\u2013171.", "ArticleIdList": ["1098584"]}, {"Citation": "Mikus J, Steverding D. Parasitol Int. 2000;48:265\u2013269.", "ArticleIdList": ["11227767"]}, {"Citation": "Borenfreund E, Babich H, Martin-Alguacil N. In Vitro Cellular & Developmental Biology: J Tissue Culture Asson. 1990;26:1030\u20131034.", "ArticleIdList": ["2177465"]}]}], "History": [{"Year": "2008", "Month": "12", "Day": "25", "Hour": "9", "Minute": "0"}, {"Year": "2008", "Month": "12", "Day": "25", "Hour": "9", "Minute": "0"}, {"Year": "2009", "Month": "2", "Day": "20", "Hour": "9", "Minute": "0"}, {"Year": "2013", "Month": "7", "Day": "18"}], "PublicationStatus": "ppublish", "ArticleIdList": ["19105653", "NIHMS91326", "PMC3715121", "10.1021/np800653z", "10.1021/np800653z"]}}], "PubmedBookArticle": []}